Terumo (OTCMKTS:TRUMY) Shares Pass Below 50-Day Moving Average - What's Next?

Key Points

• Shares fell below its 50-day moving average, trading as low as $13.00 versus the 50‑day MA of $13.13 with 262,052 shares changing hands, which could signal short‑term weakness.
• Recent quarter was mixed: Terumo reported $0.14 EPS (missing the $0.15 estimate) but beat revenue expectations at $1.94B versus $1.82B, with a net margin of 11.74%.
• Analyst stance and valuation: Nomura moved the stock to a "Hold" and the consensus is "Hold"; market cap is $19.38B with a PE of 22.66 and a low debt‑to‑equity of 0.07.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) shares crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $13.13 and traded as low as $13.00. Terumo shares last traded at $13.14, with a volume of 262,052 shares changing hands.

Analyst Ratings Changes

Separately, Nomura raised Terumo to a "hold" rating in a research report on Tuesday, February 24th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of "Hold".

Terumo Price Performance

The firm has a 50-day simple moving average of $13.13 and a 200-day simple moving average of $14.78. The firm has a market capitalization of $19.38 billion, a PE ratio of 22.66 and a beta of 0.74. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.89.

Terumo (OTCMKTS:TRUMY - Get Free Report) last released its quarterly earnings results on Friday, February 13th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Terumo had a net margin of 11.74% and a return on equity of 9.01%. The business had revenue of $1.94 billion for the quarter, compared to analysts' expectations of $1.82 billion.

Terumo Company Profile

Terumo Corporation OTCMKTS: TRUMY is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.